Structured evidence table for Maca Mood Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Maca Mood Randomized Trial | In general, risk of bias in selective reporting and incomplete data were low, and bias regarding inclusion of intention-to-treat analysis was low to moderate. | 1 | Ho Chao-Yen (2026) | Herbal dietary supplements for erectile dysfunction: A systematic review and meta-analysis of randomized-controlled trials |
| Maca Mood Randomized Trial | The analysis revealed a pooled SMD (pSMD) = 1.20 (95 % confidence interval [CI]: 0.64 to 1.76), indicating that taking herbal dietary supplements was associated with a greater improvement in erectile function as compared to controls. | 1 | Ho Chao-Yen (2026) | Herbal dietary supplements for erectile dysfunction: A systematic review and meta-analysis of randomized-controlled trials |
| Maca Mood Randomized Trial | Saffron (pSMD = 2.23, 95 % CI: 1.66 to 2.80) and ginseng (pSMD = 0.41, 95 % CI: 0.20 to 0.62) were each significantly associated with greater improvement in ED compared to that of controls, whereaswas shown to have positive effects on ED compared to controls, but the difference was not statistically significant (pSMD = 0.74, 95 % CI: −0.24 to 1.72). | 1 | Ho Chao-Yen (2026) | Herbal dietary supplements for erectile dysfunction: A systematic review and meta-analysis of randomized-controlled trials |
| Maca Mood Randomized Trial | Incidence of ED is reported to increase with increasing age.An estimated 8.3 % of insured men in the United States have been diagnosed with ED, translating to approximately 10.3 million men seeking care for this condition as of 2022. | 1 | Ho Chao-Yen (2026) | Herbal dietary supplements for erectile dysfunction: A systematic review and meta-analysis of randomized-controlled trials |
| Maca Mood Randomized Trial | By synthesizing molecular evidence from the BDNF/TrkB/CREB signaling axis and the Nrf2/NF-κB homeostatic switch, we demonstrate that this multi-target strategy offers a more robust path to neuronal resilience than traditional single-target approaches. | 4 | Cipriano GL (2026) | Phytochemical and Fungal Bioactive Compounds in the "Brain Health Triad": A Narrative Review on Neurostimulating, Neurotrophic, and Neuroprotective Synergy. |
| Maca Mood Randomized Trial | This narrative review proposes the 'Brain Health Triad' as a novel integrative framework for neurorehabilitation and cognitive enhancement, built upon three interdependent biological pillars: neurostimulation, neurotrophy, and neuroprotection. | 4 | Cipriano GL (2026) | Phytochemical and Fungal Bioactive Compounds in the "Brain Health Triad": A Narrative Review on Neurostimulating, Neurotrophic, and Neuroprotective Synergy. |
| Maca Mood Randomized Trial | We illustrate how the synergistic interplay between a 'core triad' composed of Hericium erinaceus , Bacopa monnieri , and L-Theanine targets these pillars with high specificity. | 4 | Cipriano GL (2026) | Phytochemical and Fungal Bioactive Compounds in the "Brain Health Triad": A Narrative Review on Neurostimulating, Neurotrophic, and Neuroprotective Synergy. |
Source documents